By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Sign In
Latest World News UpdateLatest World News UpdateLatest World News Update
Notification Show More
Font ResizerAa
  • Home
  • Business
  • National
  • Entertainment
  • Sports
  • Health
  • Science
  • Tech
  • World
  • Marathi
  • Hindi
  • Gujarati
  • Videos
  • Press Release
    • Press Release
    • Press Release Distribution Packages
  • Live Streaming
  • Legal Talk
Reading: Biocon Biologics gets U.S. FDA approval for biosimilar aflibercept Yesafili, enters US ophthalmology market – World News Network
Share
Latest World News UpdateLatest World News Update
Font ResizerAa
Search
  • Home
  • Business
  • National
  • Entertainment
  • Sports
  • Health
  • Science
  • Tech
  • World
  • Marathi
  • Hindi
  • Gujarati
  • Videos
  • Press Release
    • Press Release
    • Press Release Distribution Packages
  • Live Streaming
  • Legal Talk
Have an existing account? Sign In
Follow US
  • Advertise
© 2022 Foxiz News Network. Ruby Design Company. All Rights Reserved.
Latest World News Update > Blog > Business > Biocon Biologics gets U.S. FDA approval for biosimilar aflibercept Yesafili, enters US ophthalmology market – World News Network
Business

Biocon Biologics gets U.S. FDA approval for biosimilar aflibercept Yesafili, enters US ophthalmology market – World News Network

worldnewsnetwork
Last updated: May 21, 2024 12:00 am
worldnewsnetwork
Share
2 Min Read
SHARE

New Delhi [India], May 21 (ANI): Biocon Biologics announced that the U.S. Food and Drug Administration (US FDA) has approved the company’s application for YESAFILI, the company informed the exchange in a filing.
“Biocon Biologics’ Obtains U.S. FDA Approval for Biosimilar Aflibercept for Yesafili. Enters U.S. Ophthalmology Market” said the company.
After the approval, the company entered the ophthalmology therapeutic area in the United States. Earlier the company also received approvals in Europe in September and the United Kingdom in November last year, where it was the first biosimilar aflibercept to be approved.
“The FDA approval of YESAFILI (aflibercept) as the first interchangeable biological product to Eylea is a significant milestone for Biocon Biologics marking our entry into Ophthalmology, a new therapeutic area in the United States” said Shreehas Tambe, CEO and MD, Biocon Biologics.
The Company has also secured a launch date in Canada of no later than July 1, 2025, under the terms of a settlement agreement.
YESDAFILI, a vascular endothelial growth factor (VEGF) inhibitor used to treat several different types of ophthalmology conditions. YESAFILI is intended for the treatment of neovascular age-related macular degeneration, visual impairment due to macular oedema secondary to retinal vein occlusion (branch RVO or central RVO), visual impairment due to diabetic macular oedema (DME) and visual impairment due to myopic choroidal neovascularisation (myopic CNV).
“Biosimilars are crucial for making healthcare more affordable and accessible. YESAFILI will offer ophthalmologists an important new option for patients impacted by macular degeneration and diabetic retinopathy” said Matt Erick, Chief Commercial Officer, Biocon Biologics.
There are 19.8 million Americans living with age-related macular degeneration (AMD) in the United States. The sales of aflibercept in U.S. were approximately USD 5.89 billion in 2023. (ANI)


Disclaimer: This story is auto-generated from a syndicated feed of ANI; only the image & headline may have been reworked by News Services Division of World News Network Inc Ltd and Palghar News and Pune News and World News

sponsored by

WORLD MEDIA NETWORK


PRESS RELEASE DISTRIBUTION

Press releases distribution in 166 countries

EUROPE UK, INDIA, MIDDLE EAST, AFRICA, FRANCE, NETHERLANDS, BELGIUM, ITALY, SPAIN, GERMANY, AUSTRIA, SWITZERLAND, SOUTHEAST ASIA, JAPAN, SOUTH KOREA, GREATER CHINA, VIETNAM, THAILAND, INDONESIA, MALAYSIA, SOUTH AMERICA, RUSSIA, CIS COUNTRIES, AUSTRALIA, NEW ZEALAND AND MORE

Press releases in all languages

ENGLISH, GERMAN, DUTCH, FRENCH, PORTUGUESE, ARABIC, JAPANESE, and KOREAN CHINESE, VIETNAMESE, INDONESIAN, THAI, MALAY, RUSSIAN. ITALIAN, SPANISH AND AFRICAN LANGUAGES

Press releases in Indian Languages

HINDI, MARATHI, GUJARATI, TAMIL, TELUGU, BENGALI, KANNADA, ORIYA, PUNJABI, URDU, MALAYALAM
For more details and packages

Email - support@worldmedianetwork.uk
Website - worldmedianetwork.uk

India Packages

Read More

Europe Packages

Read More

Asia Packages

Read More

Middle East & Africa Packages

Read More

South America Packages

Read More

USA & Canada Packages

Read More

Oceania Packages

Read More

Cis Countries Packages

Read More

World Packages

Read More
sponsored by

You Might Also Like

US tariffs if persist longer could hit India’s growth by up to 0.8%, 6th round talks important: Morgan Stanley – World News Network

US tariffs if persist longer could hit India’s growth by up to 0.8%, 6th round talks important: Morgan Stanley – World News Network

RBI’s August policy pause a ‘technical move’, scope for a cut in 2025 limited: SBI – World News Network

Nifty, Sensex down under Tariffs pressure on Friday opening; media and metal shares shine others in red – World News Network

How Flexi Funds Align with Evolving Investor Goals and Life Stages – World News Network

Share This Article
Facebook Twitter Copy Link Print
Share
Previous Article Slovakia’s Prime Minister Fico expected to survive ‘politically motivated’ assassination attempt – World News Network
Next Article Amit Shah e-inaugurates 30 smart schools in Ahmedabad – World News Network
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Stay Connected

- Advertisement -

Latest News

Israeli cabinet approves plan to occupy Gaza City – World News Network
World August 8, 2025
China ups military incursions around Taiwan – World News Network
World August 8, 2025
Alyssa Healy returns to cricket, stars in Australia A’s victory over India A – World News Network
Sports August 8, 2025
Ballon d’Or 2025 nominees announced: Dembele, Bellingham, Yamal, Haaland in contention – World News Network
Sports August 8, 2025

Sports

Purani Dilli 6 beat West Delhi Lions in DPL thriller at Arun Jaitley Stadium – World News Network
Sports
DPL 2025: Central Delhi Kings wrap up 9-wicket win after bowling out South Delhi Superstarz for 80 – World News Network
Sports

Popular Category

  • Business
  • Entertainment
  • Health
  • Lifestyle
  • National
  • Science
  • Sports
  • Tech
  • Videos
  • World
  • Marathi
  • Hindi
  • Gujarati
  • Press Release
  • Press Release Distribution Packages

Entertainment

‘The Office’ spin-off ‘The Paper’ trailer out – World News Network
Entertainment
Radhikaraje Gaekwad stuns in century-old Paithani sari at ‘Naad’ couture showcase – World News Network
Entertainment
Latest World News UpdateLatest World News Update
Follow US
Copyright © 2023 World News Network. All Rights Reserved
Welcome Back!

Sign in to your account

Lost your password?